Invicta Diagnostic Limited sees change in partnership of subsidiary Porteus Pathogenius LLP
Invicta Diagnostic Limited has announced a change in the Designated Partner composition of Porteus Pathogenius LLP, a step-down subsidiary operating under its subsidiary, Porteus Medical LLP. The transition involves the cessation of one partner and the induction of another, while maintaining stable control by the intermediate holding entity.The development concerns the partnership constitution of Porteus Pathogenius LLP. According to the details provided, Porteus Medical LLP continues to hold a 51% partnership interest in Porteus Pathogenius LLP. The change involves Mr. Vishwajeet Arvind Burungale, who previously held a 49% partnership interest and has now retired/ceased as a Designated partner.
Mr. Mayur Shivdas Kasat has been inducted into the company as a Designated Partner and acquired the 49% partnership interest that was relinquished by Mr. Burungale. The change in personnel does not alter Porteus Medical LLP's controlling interest in Porteus Pathogenius LLP, confirming its status as a step-down subsidiary of Invicta Diagnostic Limited.
The operational details regarding the transition between the partners are presented below:
| Particulars | Mr. Vishwajeet Arvind Burungale | Mr. Mayur Shivdas Kasat |
|---|---|---|
| Reason for change | Cessation as Designated Partner along with sale of stake in Porteus Pathogenius LLP to Mr. Mayur Shivdas Kasat | Appointment as Designated Partner and acquisition of stake in Porteus Pathogenius LLP |
| Date of cessation/appointment | 20-07-2026 | 20-07-2026 |
| Brief profile | Not Applicable | Dr. Mayur Kasat is a Consultant Orthopaedics & Joint Replacement Surgeon holding MBBS, D. Ortho, FCPS (Ortho), FIJR, and FIAA qualifications. He specializes in the diagnosis and treatment of orthopaedic disorders, with a special focus on joint replacement surgery and comprehensive musculoskeletal care. |
Invicta Diagnostic Limited noted that this partnership change is not expected to have any material impact on the operations or financial position of the Company.
INVICTA Stock Price Movement
Today, Invicta Diagnostic Limited shares settled at ₹66 after closing, marking zero change in their stock price. The company saw a traded quantity of 6,400 during today's session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.